ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹554 Cr | ₹505 Cr | ₹445 Cr | ₹404 Cr | ₹347 Cr |
What is the latest Total Liabilities ratio of ANUH PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹554 Cr |
| Mar2025 | ₹505 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹404 Cr |
| Mar2022 | ₹347 Cr |
How is Total Liabilities of ANUH PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹554 Cr | 9.70 | |
| Mar2025 | ₹505 Cr | 13.32 | |
| Mar2024 | ₹445 Cr | 10.15 | |
| Mar2023 | ₹404 Cr | 16.43 | |
| Mar2022 | ₹347 Cr | - | |
Compare Total Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹801.7 Cr | -1% | 0.1% | -21.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -1% |
0.1% |
-21.9% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses